Skip to main content
. 2021 Oct 13;19:243. doi: 10.1186/s12916-021-02109-y

Fig. 4.

Fig. 4

Independent validation of the early detection classifier. A Predicted probabilities of healthy control, benign diseases, and ESCA with different clinical stages in the independent validation set. B Receiver operating characteristic curve delineating the association between predictive probability and cancer in the independent validation cohort. C Sensitivity and specificity of ESCA with early and late stages in the independent validation cohort